NEVAP INC

NeVap addresses critical unmet clinical needs with innovative medical devices, dedicated to lowering critical care costs and saving precious lives. Its mission is to reduce Ventilator-Associated Pneumonia, a common, serious, deadly, and expensive hospital-acquired infection problem in modern medicine. The company has developed the NeVap Aspire Subglottic Suction Endotracheal Tube, an FDA & CE Mark cleared device that allows for infection protection in the operating room, intensive care unit, and emergency department.